Sale by ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC
Enliven Therapeutics, Inc.
Transaction date
- Shares
- 46,776
- Price per share
- 45.00
People / SEC CIK 0001760648
Insider transactions reported to the SEC
Browse linked events from SEC filings within FilingRelay's coverage.
Allow Google Analytics to measure visits and clicks on SEC source links. You can change your choice at any time.